ArticleArthritis research & therapy2026

DNA methylation inhibitor decitabine ameliorates spondyloarthritis by suppressing Th17 responses and epigenetically upregulating VIPR1 in SKG mice.

Hoshiko Furusawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.